As we reached the end of June last week, we review moves from smid-cap biopharma companies during the month of June. See Table 1 for...

As we reach the end of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...

$XBI $74.27 | -0.71% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #HGEN -4% NIH/NIAID Locks...

$XBI $74.27 | -0.71% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #HGEN -4% NIH/NIAID Locks...

$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...

$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...

As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...

$XBI $76.23 | +6.18% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +14% Novavax Files...

$XBI $76.23 | +6.18% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +14% Novavax Files...

$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...

$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...

Summary Over 40 Smid-Cap companies currently have active trials involving COVID therapeutics (this includes small molecules and...